ADMA Biologics ADMA D&A

D&A at other companies

AbCellera Biologics Inc.ABCL

$6.1M+32.6%

Lifecore Biomedical, Inc.LFCR

$2.52M—

AnaptysBio, Inc.ANAB

$130K-11.0%

Absci CorporationABSI

$2.73M-11.2%

Avalo TherapeuticsAVTX

$17K-87.3%

Apogee Therapeutics, Inc.APGE

$408K+97.1%

FAQ

What is ADMA Biologics's D&A?

ADMA Biologics (ADMA) reported D&A of $1.7M in Q2 2026.

How has ADMA Biologics's D&A changed year-over-year?

ADMA Biologics's D&A decreased by 15.0% year-over-year, from $2M to $1.7M.

What is the long-term trend for ADMA Biologics's D&A?

Over 4 years (2021 to 2025), ADMA Biologics's D&A has grown at a 9.5% compound annual growth rate (CAGR), from $5.5M to $7.9M.

What does D&A mean?

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.